Face Serum

After 28 days of twice daily use, study subjects showed signs of significant improvement in:

After 28 days of twice daily use, study subjects showed signs of significant improvement in:

Results Based On Evaluation Of Clinical Trial Participants

After 28 days of twice daily use, study subjects showed signs of significant improvement in:

ANTI-WRINKLE

92%

believe that wrinkles are reduced

92%

believe wrinkles are filled

96%

believe this serum reduces the appearance of fine lines & wrinkles

Tighter Skin

93%

believe their skin looks lifted and tighter

Firmness

100%

believe their skin feels plump and firmer

100%

believe their skin is regenerated and smooth

96%

believe their skin looks and feels balanced

Results Based On Measurable Clinical Data

FIRMNESS

Day 0
0.474
Day 28
0.368

+22%

a significant improvement in cutaneous firmness

Firmer skin was observed in 100% of subjects.

BIOLOGICAL ELASTICITY

Day 0
0.522
Day 28
0.697

+33%

improvement in cutaneous biological elasticity

More elastic skin was observed in 73% of subjects

RAW ELASTICITY

Day 0
0.288
Day 28
0.368

+28%

improvement in raw elasticity

More elastic skin was observed in 77% of subjects

Moisturizing (cutaneous hydration rate)

Day 0
49.7
Day 28
57.1

15%

improvement in hydration level

96% of subjects presenting an improvement

Anti-Wrinkle (average relief)

Day 0
71.4
Day 28
68.3

+65%

anti-wrinkle effect

A tendency to less wrinkled skin was observed in 65% of subjects

ANTI-WRINKLE (maximum relief)

Day 0
122.9
Day 28
116.3

+70%

anti-wrinkle effect

A tendency to less wrinkled skin was observed in 70% of subjects

EVALUATION OF THE OCULAR POTENTIAL IRRITANCY OF A COSMETIC PRODUCT BY DETERMINATION OF THE CYTOTOXICITY AFTER DIFFUSION IN AGAROSE GEL

The cytotoxicity is evaluated by measuring the mean diameter (MD) of cell lysis on 4 dishes and calculating the mean. This value is presented in centimeters, to one decimal place.

AVL reference product

MD [cm]

Classification

Conclusion

Face Serum

0.0

Low cytotoxicity

The test item does not have irritant properties

EVALUATION OF THE SKIN COMPATIBILITY OF A COSMETIC PRODUCT AFTER ONE SINGLE APPLICATION ON ADULT SUBJECTS UNDER DERMATOLOGICAL CONTROL: SINGLE PATCH TEST

100 subjects – 50 sensitive skin and 50 normal skin, where M.C.I.I. = Mean Cumulative Irritation Index

AVL reference product

Skin Type

Concentration / Type

Patch duration

M.C.I. I.

Conclusion

Face Serum

Normal

20 μl Pure / Occlusive

48 hours

0.12

Non irritating

Face Serum

Sensitive

20 μl Pure / Occlusive

48 hours

0.06

Non irritating